Biotechnology & Pharmaceutical Services Outsourcing Market Expected To Trigger A Revenue To USD 108.0 Billion By 2030: Grand View Research, Inc.

 Biotechnology & Pharmaceutical Services Outsourcing Market Growth & Trends

The global biotechnology and pharmaceutical services outsourcing market size is expected to reach USD 108.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2022 to 2030. The COVID-19 pandemic has significantly impacted Biotechnology and Pharmaceutical third-party service providers as well as clinical trials, resulting in trial delay, suspensions, and terminations. The global crisis has stressed the need for virtual trials and leveraging technology and software solutions. The recovery from the pandemic has led to increasing adoption of machine learning-based platforms, artificial intelligence, automation in drug manufacturing, and innovative trial designs are projected to transform the CRO and CMO landscape in the coming years.

Biopharmaceutical and pharmaceutical investments in novel and innovative therapies, for instance, regenerative medicine, are driving the R&D activity together with drug development services. The high demand for biologics along with small molecules has led to the expansion of service portfolios of Contract Manufacturing Organizations (CMOs)/Contract Research Organizations (CROs) for biotechnology and pharmaceutical production. Small pharma/ biotech companies are facing challenges while performing in-house development, manufacturing, regulatory affairs, product maintenance, product design and development, product testing and validation, and training and education such as lack of substantial expertise and expensive capability. This in turn has created lucrative opportunities for the growth of CMOs and CROs. Contract services are growing and becoming strategic, targeted, and planned. These factors are expected to play a pivotal role in enhancing the share of CMOs/CROs in the overall market.

Growing pricing pressure, regulatory challenges, and patent expiration have led to shrinking margins in the biotech and pharmaceutical industry. Contract services are considered a “strategic competitive weapon” among the companies, as these services help overcome these issues. These services offer cost saving to their clients as choosing sustainable suppliers could lead to reduced costs in the long run. They also help save time utilized in the operations and management of a production and research facility. Contract research and manufacturing allows low-cost product development and manufacturing cost of a product. Furthermore, outsourcing services assist in overcoming trade barriers and facilitate the entry of firms into the foreign market. Owing to these advantages, several firms choose to outsource services rather than investing capital in production equipment and hiring skilled labor.

The biologics industry has grown substantially in recent years to include novel product types including nanobodies, rDNA, synthetic vaccines, fusion proteins, soluble receptors, immunoconjugates, and immunotherapeutics. Owing to the revolutionization of disease therapy through biologics, this sector has also provided many opportunities to explore hybrid structures that combine biologics with well-defined chemical entities. The significant growth of biologics is expected to drive the demand for outsourcing of biologics development and manufacturing.

Request a free sample copy or view report summary: Biotechnology & Pharmaceutical Services Outsourcing Market Report

Biotechnology & Pharmaceutical Services Outsourcing Market Report Highlights

• The consulting segment is expected to dominate the market with a share of 19.5% in 2021. Owing to the increase in the number of fraudulent cases, discrepancies in intellectual property rights, and rise in technological innovations
• Based on service, the others segment is expected to witness the highest CAGR of 6.4% over the forecast period owing to increasing focus on generic and biosimilarin developing regions
• The pharma segment is expected to witness a CAGR of 5.7% over the forecast period as the pharmaceutical companies outsource internal activities at a larger scale due to rising pricing pressure, and growth of generics in the industry
• North America dominated the market and accounted for the largest revenue share of 53.8% in 2021 due to the presence of a large number of biotechnology and pharmaceutical companies and the quality of services offered by the CROs and CMOs in the region
• In Asia Pacific, the market is anticipated to register the highest CAGR of 6.1% over the forecast period owing to improved regulatory frameworks, the high scope for cost savings, and the presence of cheap skilled personnel

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biotechnology-pharmaceutical-services-outsourcing-market

Biotechnology & Pharmaceutical Services Outsourcing Market Segmentation

Grand View Research has segmented the global biotechnology and pharmaceutical services outsourcing market based on service, end-use, and region:

Biotechnology & Pharmaceutical Services Outsourcing Service Outlook (Revenue, USD Million, 2018 - 2030)

• Consulting
  • Regulatory compliance
  • Remediation
  • Quality management systems consulting
  • Others
• Auditing and assessment
• Regulatory affairs
  • Clinical trial applications & product registration
  • Regulatory writing & publishing
  • Legal representation
  • Others
• Product maintenance
• Product design & development
• Product testing & validation
• Training & education
• Others

Biotechnology & Pharmaceutical Services Outsourcing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma
• Biotech

Biotechnology & Pharmaceutical Services Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Biotechnology & Pharmaceutical Services Outsourcing Market

• Parexel International Corporation
• The Quantic Group
• IQVIA
• Lachman Consultant Services, Inc.
• GMP Pharmaceuticals Pty Ltd.
• Concept Heidelberg GmbH
• Covance Inc.
• Charles River Laboratories
• PRA Health Sciences
• ICON plc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In Silico Clinical Trials Market to Reach USD 5.1 Billion by 2030: Grand View Research Inc.

 In Silico Clinical Trials Market Growth & Trends

The global in silico clinical trials market size is expected to reach USD 5.1 billion by 2030 and is projected to expand at a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. Traditional clinical trials require huge expenditure to conduct research. Moreover, a high number of drugs and medical devices fail in the clinical trial owing to the lack of safety and efficacy, which creates huge losses for the clinical trial sponsors. These factors promote the demand for in silico clinical trials, to understand the behavior of drugs or medical devices in humans. In silico clinical trials use simulation techniques to understand the efficacy and safety of a drug or medical device.

This reduces the chances of adverse reactions, thus, improving the safety and efficacy of research studies. The market players are making significant investments to provide new treatments to the people. For instance, in June 2021, In silico Medicine raised USD 255 million in funding to boost its R&D for drug discovery, through in silico studies. The demand for in silico clinical trials was also improved during the pandemic as there was a temporary shutdown of clinical research sites and several studies for vaccines and therapeutic agents for COVID-19 were performed through in silico research models. Such actions are likely to have a positive impact on market growth.

Request a free sample copy or view report summary: In Silico Clinical Trials Market Report

In Silico Clinical Trials Market Report Highlights

• The medical device segment dominated the market in 2021 owing to the fact that the majority of in silico trials are performed for medical devices globally
• The phase II segment accounted for the largest market revenue share in 2021
• The oncology therapeutic area segment accounted for the largest market revenue share in 2021
• The cancer clinical trials have high chances of incurring adverse effects on patients, which promotes the demand for in silico trials for cancer
• North America held the largest revenue share in 2021 due to the presence of several global players operating in the market
• In addition, a significant number of in silico trials are performed in the U.S., which further contributes to the growth of the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-insilico-clinical-trials-market

In Silico Clinical Trials Market Segmentation

Grand View Research has segmented the global in silico clinical trials market on the basis of industry, therapeutic area, phase, and region:

In Silico Clinical Trials Industry Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Devices
• Pharmaceutical

In Silico Clinical Trials Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Infectious Disease
• Hematology
• Cardiology
• Dermatology
• Neurology
• Diabetes
• Others

In Silico Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

In Silico Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of In Silico Clinical Trials Market

• Certara, Inc.
• Novadiscovery Sas
• Insilico Medicine, Inc.
• Dassault Systemes SE
• GNS Healthcare Inc.
• The AnyLogic Company
• InSilicoTrials
• Immunetrics Inc.
• Nuventra Pharma Sciences
• Abzena Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Valuable Foresights on How Pet Insurance Market will Grow During 2022 – 2030: Grand View Research Inc.

 Pet Insurance Market Growth & Trends

The global pet insurance market size is anticipated to reach USD 32.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 16.7% from 2022 to 2030. The key factors driving the market growth include the rising number of pets across the globe, high veterinary care costs, and the need to reduce financial risk. As per the Pet Food Manufacturers Association, about 59% of households had pets in the U.K. in 2021. Dogs were the most popular at about 33%, followed by cats at 27%. Other pets include rabbits, indoor birds, guinea pigs, tortoises and turtles, horses, and others.

The COVID-19 pandemic has impacted all industries, including the market. The surge in pet ownership during the pandemic, expenditure on pets, and increasing pet humanization further supported the adoption of pet insurance policies during 2020 and 2021. Concerns over rising veterinary care costs and fear of transmission of COVID-19 from pets to pet owners also increased the demand for reducing financial risks with a suitable pet insurance policy. Although OIE has confirmed that no animals can spread this virus. However, in the initial months of the pandemic, there was speculation that it may spread through birds. Overall, the pandemic positively impacted the market with increased awareness and adoption of insurance policies by pet parents.

Rapidly growing consumer awareness, underpenetrated market, and product acceptance have benefited the market. According to Petplan, in the U.S., the average cost of an unexpected visit to the veterinarian was around USD 800-1,500 in 2018. This burden could be eased with an insurance plan in place. Moreover, untapped opportunities in developed and developing economies are anticipated to provide lucrative growth to this market in the coming years. Furthermore, advancements in pet insurance, such as vet direct pay by Trupanion, are revolutionizing medical insurance for cats and dogs by eliminating the reimbursement model. Similarly, pet insurance in Europe is growing rapidly due to strict pet insurance regulations in countries such as Sweden.

In addition, strategic initiatives by market players are further expected to boost the market growth. For instance, in April 2020, Zoetis entered the pet insurance space by launching Pumpkin Insurance Services Inc.- a pet insurance agency across the U.S. The company offers competitive pet health insurance plans and preventive care plans to pet parents. In December 2019, MetLife, Inc. on the other hand, acquired PetFirst Healthcare, LLC - a companion animal health insurance administrator. This acquisition leveraged the company’s position as a leader in group benefits distribution channels in the U.S. by enabling MetLife to expand its offerings. Such initiatives are estimated to boost the market growth in the coming years. Insurance providers are also focused on increasing penetration by targeting the customer base of the sales channels. For instance, in February 2018, Healthy Paws collaborated with Roover.com to increase its market penetration.

Request a free sample copy or view report summary: Pet Insurance Market Report

Pet Insurance Market Report Highlights

• The market was valued at USD 8.3 billion in 2021 and is expected to witness a CAGR of 16.7% during the forecast period
• The dogs insurance segment held the highest share of the market in 2021. The high popularity of dogs as pets and increase in the number of dog pet owners across the globe are the key drivers for this segment
• The direct sales segment dominated the market in 2021 while the others segment is estimated to grow the fastest over the forecast period
• Market players are utilizing various sales channels to distribute their insurance products and increase their market share. Bancassurance, for instance, held a notable share of the market in 2021. This is due to growing collaborations between pet insurance companies and banks. For instance, in April 2018, CIMB Bank in Singapore was the first to launch pet insurance for a wide variety of pets
• Based on coverage type, the accident and illness coverage segment accounted for the largest revenue share in 2021. The key drivers of the segment include high veterinary treatment and diagnostic cost, the rise of the companion animal population, and an increase in the awareness of pet insurance
• The accident only segment held a substantial share of the market in 2021. The key drivers of the segment include increasing health issues in animals and high treatment cost
• In 2021, Europe held the dominant share of the market. European countries were found to have a higher rate of pet insurance penetration along with the presence of key market players
• North America held the second-largest revenue share as of 2021. The key drivers of the market are a rise in the companion animal population and an increase in awareness related to pet insurance

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pet-insurance-market

Pet Insurance Market Segmentation

Grand View Research has segmented the global pet insurance market on the basis of coverage type, animal type, sales channel, and region:

Pet Insurance Coverage Type Outlook (Revenue, USD Million, 2017 - 2030)

• Accident & Illness
• Accident only
• Others

Pet Insurance Animal Type Outlook (Revenue, USD Million, 2017 - 2030)

• Dogs
• Cats
• Others

Pet Insurance Sales Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Agency
• Broker
• Direct
• Bancassurance
• Others

Pet Insurance Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Netherlands
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • Israel

List of Key Players of Pet Insurance Market

• Trupanion, Inc.
• Deutsche Familienversicherung AG (DFV)
• Petplan (Allianz)
• Animal Friends Insurance Services Limited
• Figo Pet Insurance, LLC
• Direct Line
• Nationwide Mutual Insurance Company
• Embrace Pet Insurance Agency, LLC
• Anicom Insurance
• ipet Insurance Co., Ltd.
• MetLife Services and Solutions, LLC
• Pumpkin Insurance Services Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microdermabrasion Devices Market is Projected to Boost USD 984.7 Million by 2030: Grand View Research Inc.

 Microdermabrasion Devices Market Growth & Trends

The global microdermabrasion devices market size is expected to reach USD 984.7 million by 2030, registering a CAGR of 8.6%, according to a new report by Grand View Research, Inc. Growing cases of skin-related conditions is a major factor driving the market growth. Moreover, high demand for anti-aging treatments due to the growing geriatric population will boost the market. Increasing demand for cosmetic procedures is also anticipated to fuel market growth.

For instance, according to the American Society of Plastic Surgeons article, Americans spent nearly at least USD 16.5 billion on minimally invasive procedures and cosmetic plastic surgeries in 2018, which reflects a nearly 4% increase from 2017. Moreover, many cosmetic and plastic procedures are performed as a combination of more than one procedure, thus driving the market growth. In addition, the introduction of new products for the treatment of various skin disorders is estimated to augment the market growth in future. Some of the key companies in the global microdermabrasion equipment market are Silhouet-Tone, Dermaglow, Koninklijke Philips N.V., and Skin for Life.

Request a free sample copy or view report summary: Microdermabrasion Device Market Report

Microdermabrasion Device Market Report Highlights

• Diamond microdermabrasion devices are expected to account for the largest markets hare as they are non-invasive, highly effective, and help increase blood flow and production of collagen in the skin
• Others application segment held the largest microdermabrasion machine market share in 2018 and is expected to lead in the future as well owing to increasing demand for skin-related procedures for various conditions and preference for non-invasive procedures
• Anti-aging is the fastest-growing application due to factors, such as growing geriatric population, demand for non-invasive procedures, and well-established healthcare infrastructure in developed economies
• Clinics and beauty centers segment is expected to lead the microdermabrasion systems market during the forecast period owing to availability of skilled professionals in these centers
• North America held a substantial market share in 2018 due to high demand for non-invasive techniques and presence of advanced medical infrastructure and a large number of dermatologists

Access Press Release@ https://www.grandviewresearch.com/press-release/global-microdermabrasion-device-market

Microdermabrasion Device Market Segmentation

Grand View Research has segmented the microdermabrasion devices market on the basis of type, application, end use, and region:

Microdermabrasion Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• Crystal
• Diamond

Microdermabrasion Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Acne & scars
• Photo damage
• Anti-aging
• Hyperpigmentation
• Stretch marks
• Others

Microdermabrasion Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Clinics & Beauty Centers
• Home Use

Microdermabrasion Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List Of Key Players Of Microdermabrasion Devices Market

• Johnson & Johnson
• Skin for Life
• Altair Instruments
• Dermaglow
• PMD
• Silhouet-Tone
• Lumenis Ltd.
• Koninklijke Philips N.V.
• Envy Medical, Inc.
• The HydraFacial Compan

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Regulatory Affairs Outsourcing Market to Partake Significant Development During 2022 to 2030: Grand View Research Inc.

 Regulatory Affairs Outsourcing Market Growth & Trends

The global regulatory affairs outsourcing market size is expected to reach USD 13.9 billion by 2030, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Significant increase in the fixed costs of in-house resources for regulatory affairs & operation activities like training, technology, specialized knowledge, and facilities are driving outsourcing of regulatory affair functions. Addressing local regulatory challenges and constant changes in the regulations of the major markets, such as the U.S., Europe, and Asia, is creating demand for these services. Compliance with the current regulations has become an immense chore, leave alone trying to stay up to date with developments around the world. Amendments to current regulations are likely to simplify the regulatory pathway for the industry but in turn, complicate the operation for healthcare product manufacturing companies.

Thus, leading to the regulatory affairs outsourcing to service providers. The market witnessed a significant decline in 2020 due to the outbreak of the COVID-19 pandemic, as there was a halt in clinical trial activities including regulatory updates. Disruption in the supply chain and closure of R&D sites resulted in a significant loss of revenues in 2020 across the industry. However, due to the pandemic, various healthcare companies are opting for more regulatory advice, as companies push to speed up the product development & approvals in therapies, vaccines, & devices for COVID-19. Owing to the urgent need for medical devices and therapies for COVID-19, regulatory authorities are providing emergency use authorization for the majority of products. Such actions have further promoted the demand for these services post 2020 and the positive rebound of sales across the industry can be witnessed from 2021.

Request a free sample copy or view report summary: Regulatory Affairs Outsourcing Market Report

Regulatory Affairs Outsourcing Market Report Highlights

• The regulatory writing & publishing services segment dominated the market with the maximum revenue share in 2021as they are offered from the early stages of development to the post-marketing authorization phase and are vital for the success of a product
• The large companies segment is projected to witness the fastest CAGR during the forecast period. The availability of a wide variety of services and the presence of these providers in various geographies are the key factors driving the segment growth
• The clinical studies stage segment accounted for the largest market share in 2021 due to the increasing demand for clinical trials in developing countries
• The pharmaceutical companies end-use segment is anticipated to witness the fastest growth rate over the forecast period due to evolving areas, such as orphan drugs and personalized therapies
• Asia Pacific held the maximum revenue share of the global market in 2021 owing to higher off shoring of such services into regions of economic benefits and the expansion of life sciences companies in countries, such as India & China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-regulatory-affairs-outsourcing-market

Regulatory Affairs Outsourcing Market Segmentation

Grand View Research has segmented the global regulatory affairs outsourcing market based on services, company size, category, indication, stage, end user, and region:

Regulatory Affairs Outsourcing Services Outlook (Revenue, USD Million, 2018 - 2030)

• Regulatory Consulting
• Legal Representation
• Regulatory Writing & Publishing
• Product Registration & Clinical Trial Applications
• Other Services

Regulatory Affairs Outsourcing Company Size Outlook (Revenue, USD Million, 2018 - 2030)

• Small
• Medium
• Large

Regulatory Affairs Outsourcing Category Outlook (Revenue, USD Million, 2018 - 2030)

• Drugs
  • Generics
  • Innovators
• Biologics
  • Biotech
  • ATMPs
  • Biosimilars
• Medical Devices
  • Therapeutic
  • Diagnostic

Regulatory Affairs Outsourcing Stage Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical
• Clinical
• PMA (Post Market Authorization)

Regulatory Affairs Outsourcing Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Neurology
• Cardiology
• Immunology
• Others

Regulatory Affairs Outsourcing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies

Regulatory Affairs Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Turkey
  • The Netherlands
  • Switzerland
  • Sweden
  • Europe CIS Countries
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
  • Asia Pacific CIS Countries
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

List of Key Players of Regulatory Affairs Outsourcing Market

• Accell Clinical Research, LLC
• GenPact Ltd.
• Criterium, Inc.
• PRA Health Sciences
• Promedica International
• Regenold GmbH
• BioMapas
• Zeincro Group
• Medpace     
• ICON plc
• Covance
• Parexel International Corp.
• Freyr

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Organic Wine Market Expected to Witness a Sustainable Growth over 2030: Grand View Research Inc.

 Organic Wine Market Growth & Trends

The global organic wine market size is anticipated to reach USD 21.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.2% from 2022 to 2030. The market is predominantly driven by the rising awareness regarding health among consumers across the globe. The demand for organic products is increasing at a fast pace. Consumers are spending more on chemical-free and organic products mainly in North America and Europe. According to Organic Trade Association (OTA), 75 million millennials in America are consuming organic food and drinks. Parents in the age group 18 to 34 years are the largest group of organic buyers in the U.S.

According to OTA, organic food sales surpassed USD 56.0 billion in 2020, 12.8% up from the previous year’s sales. This growth of organic products is expected to drive the market globally. Wine has become an important part of many European cultures and is considered a standard accompaniment at dinner and lunch. As per the study conducted by the ChaireVins et Spiritueux de INSEEC U and the European Association of Wine Economists in 2020, the consumption frequency of wine has risen remarkably during the home isolation period due to the Coronavirus outbreak in Spain and other countries in Europe

The outbreak of Coronavirus disrupted the global organic wine supply chain and distribution channel owing to the closure and restrictions on bars, restaurants, and hotels globally. According to the 2020 ProWein Business Report, the COVID-19 affected around 77% of hotels, with turnover declining by 60% across the sector, while restaurants saw sales decline by 91% by the end of 2020. However, in many regions, the wine market has extremely benefited from the lockdown and travel restrictions. Consumers enjoyed wine across a broader range of at-home occasions. For instance, according to Wine Intelligence, the wine market of Brazil gained approximately three million regular wine drinkers (which is at least once a month) between 2019 and 2020.

Request a free sample copy or view report summary: Organic Wine Market Report

Organic Wine Market Report Highlights

• The canned organic wine segment is expected to register CAGR of 14.2% over the forecast period. According to Wine Australia (an Australian government agency), The sales of bottled wine are declining while canned wine is making an entrance in Australia. Canned winewas not recorded as a separate category until 2018. But in the last twelve months between March 2018 and March 2019, the canned wine sales grew from less than 100,000 liters to 1 million liters in retail
• The red organic wine segment dominated the market and is driven by France and Germany. The segment accounted for a 61.4% revenue share in 2021. The red organic wine has the highest share, even in the largest organic white wine consumer country, Germany. Cabernet Sauvignon, Merlot, Zinfandel, Syrah, Malbec, and Pinot Noir are some of the popular red organic wines consumers, worldwide
• The off-trade segment is projected to witness a CAGR of 10.7% over the forecast period. The supermarkets and hypermarkets sub-segments dominated the off-trade segment in 2021. COVID-19 pandemic increased the off-trade sales of wines. Several factors such as work from home, strict rules in pubs and bars like wearing a mask, and the anxiety related to COVID-19 have driven consumers to purchase organic wine directly from retail outlets
• Germany is the world’s largest market for organic wine with a share of 32.3% in Europe in 2021. As per the report published by USDA Foreign Agriculture Services in 2020, in Europe, Germany is among the top five wine producers in the European Union (EU). It ranks fourth in the production of wine after France, Italy, and Spain. German wine production from the 2019 harvest for marketing in 2020 was estimated at 8.4 million hectoliters. Germany is also among the largest importers of wine in terms of volume
• Australia is the second-largest market for organic wine in Asia Pacific and the consumption of wines is increasing in the country. According to Wine Australia, the country is among the top 10 consumers of wine in the world. The country accounts for 2% of the global wine consumption

Access Press Release@ https://www.grandviewresearch.com/press-release/global-organic-wine-market

Organic Wine Market Segmentation

Grand View Research has segmented the global organic wine market on the basis of type, packaging, distribution channel, and region:

Organic Wine Type Outlook (Revenue, USD Million, 2017 - 2030)

• Red Organic Wine
• White Organic Wine

Organic Wine Packaging Outlook (Revenue, USD Million, 2017 - 2030)

• Bottles
• Cans
• Others

Organic Wine Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• On-trade
• Off-trade

Organic Wine Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa

List of Key Players of Organic Wine Market

• Avondale
• Elgin Ridge Wines
• Kendall-Jackon Winery
• The Organic Wine Company
• Bronco Wine Company
• King Estate Winery
• Grgich Hills Estate
• Emiliana Organic Vineyards
• Societa Agricola QuerciabellaSpA
• Frey Vineyards

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market for Healthcare Contract Research Organization to Reflect Steadfast Expansion During 2022-2030: Grand View Research Inc.

 Healthcare Contract Research Organization Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 74.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2022 to 2030. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trial costs and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to CROs. Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure, expertise, and minimize their cost and timelines. The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites.

However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market. Owing to the pandemic, the players of the CRO market built powerful tools to support virtual clinical trials, so as to assist sponsors of the trials. Such actions are likely to improve market growth. 

Request a free sample copy or view report summary: Healthcare Contract Research Organization Market Report

Healthcare Contract Research Organization Market Report Highlights

• Based on type, the clinical segment has dominated the market in 2021, with the largest share of 76.4%, owing to the fact that it comprises four elaborate phases, including human subjects. The significant demand for new treatments has further contributed to the growth of the segment
• Among services, the clinical monitoring segment was the largest in terms of both the market share and revenue in 2021
• North America held a significant market share of 25.3% in 2021 due to the presence of several global players, who invest a major part of their revenue in research activities
• In Asia Pacific, the market is anticipated to witness lucrative growth of 8.0% over the forecast period due to the reduced cost it offers in comparison to the U.S and other developed economies
• China, Japan, and India are projected to witness tremendous growth in the market over the forecast period owing to high disease prevalence in these countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-cro-market

Healthcare Contract Research Organization Market Segmentation

Grand View Research has segmented the global healthcare Contract Research Organization (CRO) market on the basis of type, service, and region:

Healthcare CRO Type Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Discovery
  • Target Validation
  • Lead Identification
  • Lead Optimization
• Pre-Clinical
• Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

Healthcare CRO Service Outlook (Revenue, USD Million, 2018 - 2030)

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and site Recruitment
• Technology
• Others

Healthcare CRO Application Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Cardiovascular
• Autoimmune/Inflammation
• Central nervous system (CNS)
• Dermatology
• Infectious diseases
• Diabetes
• Pain
• Others

Healthcare CRO End use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Others

Healthcare Contract Research Organization (CRO) Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Switzerland
  • Belgium
  • Netherlands
  • Austria
• Asia Pacific
  • India
  • China
  • Japan
  • Korea (Republic)
  • Taiwan
  • Australia
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iran
  • Israel

List of Key Players of Healthcare Contract Research Organization (CRO) Market

• ICON Plc
• Charles River Laboratories (CRL)
• Syneos Health
• IQVIA HOLDINGS INC.
• GVK Biosciences Private Limited
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• PAREXEL INTERNATIONAL CORPORATION
• Medidata Solutions, Inc.
• Pharmaron
• SGS SA
• KCR S.A.
• CTI Clinical Trial & Consulting
• PSI CRO AG
• Clintec
• Worldwide Clinical Trials
• Wuxi AppTec
• Advanced Clinical
• Pharm-Olam, LLC
• Clinipace

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ocular Implants Market Trends, Growth Prospects To 2030: Grand View Research Inc.

 Ocular Implants Market Growth & Trends

The global ocular implants market size is expected to reach USD 22.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.8% from 2022 to 2030. Increasing focus on the development of technologically advanced products is expected to drive the market. Additionally, the growing incidence of eye disorders such as glaucoma, cataract, and age-related macular degeneration is predicted to propel the demand for ocular implants. According to the World Glaucoma Association, an estimated 79.6 million individuals were anticipated to have glaucoma in 2020.

Due to the imposition of multiple lockdown restrictions, travel restrictions, and complete lockdowns in many countries, the economies worldwide have observed a major loss moving it into a state of recession. The COVID-19 impact was also strongly felt across the healthcare systems. While certain markets witnessed a major rise in demand due to the need for ocular implants in diagnoses and the treatment of COVID-19, certain other products observed a sharp fall in sales, especially during the peak of the pandemic. The market belonged to the latter and witnessed a negative impact due to the outbreak of COVID-19. The cancellation and postponement of elective surgeries in order to avoid the transmission of the virus to the staff and patients led to a fall in the sales of ocular implants in 2020.

However, the introduction of vaccines and specific strategies based on earlier experience to curtail the similar impact of the third or fourth wave in most countries is helping the market to regain its growth. Additionally, the outbreak of COVID-19 has created a higher preference among patients to visit specialty eye institutes rather than hospitals in order to avoid crowded places that pose a higher threat of contracting the virus, thereby increasing the demand for specialty clinics. Moreover, the new dynamics involved in the occupation and education system have increased the overall screen-time of individuals, which is expected to contribute to the rising incidence of eye diseases. This, in turn, is expected to enhance the market growth during the forecast period.

Request a free sample copy or view report summary: Ocular Implants Market Report

Ocular Implants Market Report Highlights

• The glaucoma implants product segment dominated the market in 2021 owing to the growing incidence of glaucoma globally
• The glaucoma surgery application held the largest revenue share in 2021 and this trend is expected to continue during the forecast period
• By end use, the hospitals segment dominated the market with a revenue share of more than 40.0% in 2021 due to the increasing number of hospital admissions across the globe
• The specialty eye institutes end-use segment is expected to witness significant growth during the forecast period owing to the rising need for eye care services in remote areas
• Asia Pacific is anticipated to register the highest CAGR of 7.1% over the forecast period due to the increase in the diabetic population in this region, which is highly susceptible to developing eye disorders

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ocular-implants-market

Ocular Implants Market Segmentation

Grand View Research has segmented the global ocular implants market based on product, application, end use, and region:

Ocular Implants Product Outlook (Revenue, USD Million, 2017 - 2030)

• Intraocular Lens
• Corneal Implants
• Orbital Implants
• Glaucoma Implants
• Ocular Prosthesis
• Others

Ocular Implants Application Outlook (Revenue, USD Million, 2017 - 2030)

• Glaucoma Surgery
• Oculoplasty
• Drug Delivery
• Age-related Macular Degeneration
• Aesthetic Purpose

Ocular Implants End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Specialty Eye institutes
• Clinics

Ocular Implants Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE

List of Key Players of Ocular Implants Market

• Alcon, Inc.
• Bausch & Lomb, Inc.
• Carl Zeiss AG
• Johnson & Johnson
• STAAR Surgical Company
• Morcher GmbH
• Hoya Corporation
• Glaukos Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-acne Dermal Patch Market Size, Share, Trends, Analysis And Growth Forecast To 2030: Grand View Research Inc.

 Anti-acne Dermal Patch Market Growth & Trends

The global anti-acne dermal patch market size is expected to reach USD 870.3 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. The growing prevalence of acne vulgaris is boosting the adoption of instant treatments pertaining to the conditions such as acne patches, thus propelling market growth. There has been a surge in the number of anti-acne dermal patch brands being commercialized across the globe. Hence, increasing product launches in this industry have significantly boosted its revenue growth. Moreover, the rising number of companies expanding their geographic presence across the developing as well as developed economies have further supported the market’s positive growth trajectory across the forecast period.

However, the pandemic of COVID-19 has made the anti-acne dermal patch industry witness a negative drop in its growth rate in 2020. The parent market of beauty and personal care has reflected a significant decline in its revenue growth across the year 2020. Closure of retail stores, pharmaceutical outlets during the initial period of the COVID-19 outbreak has resulted in severe disruption of the profit model of such industries. However, the COVID-19 outbreak has also resulted in a sudden spike in demand for E-commerce platforms such as Amazon and a few others. Online platforms delivering beauty and personal care products including anti-acne dermal patches have witnessed strong growth during the last quarter of 2020, thus mitigating the negative impact on the business up to a certain extent.

Furthermore, the increasing trend of social media marketing is another crucial factor boosting the adoption of acne patches. For instance, in August 2019, Hero Cosmetics launched an influencer campaign on TikTok, promoting its anti-acne dermal patch by featuring 20 creators who posted videos of their morning routines with Hero's Mighty Patch product, thus attracting a large group of customers and thereby propelling its revenue growth.

Request a free sample copy or view report summary: Anti-acne Dermal Patch Market Report

Anti-Acne Dermal Patch Market Report Highlights

• The 18 to 44 segment dominated the market with a share of 55.2% in 2021. The high incidence of acne vulgaris among this age group is one of the prominent factors supporting its share
• The chemical-based anti-acne dermal patch segment accounted for the largest share of 88.3% in 2021
• Asia Pacific held the largest revenue share of 39.8% in 2021. The presence of large numbers of players in countries such as South Korea offerings novel herbal-based acne patches is responsible for market growth. The region is also expected to witness the highest growth over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-anti-acne-dermal-patch-market

Anti-acne Dermal Patch Market Segmentation

Grand View Research has segmented the global anti-acne dermal patch market based on type, age group, distribution channel, and region:

Anti-Acne Dermal PatchType Outlook (Revenue, USD Million, 2018 - 2030)

• Chemical based
• Herbal based

Anti-Acne Dermal PatchAge Group Outlook (Revenue, USD Million, 2018 - 2030)

• 10 to 17
• 18 to 44
• 45 to 64
• 65+

Anti-Acne Dermal PatchDistribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail Stores
• Pharmacies & Drug Stores
• E-Commerce Platform

Anti-Acne Dermal PatchRegional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia 

List of Key Players of Anti-acne Dermal Patch Market

• Peter Thomas Roth Labs LLC
• Rael
• ZitSticka
• 3M
• Starface
• DermaAngel
• Hero Cosmetics
• Sephora USA, Inc.
• Urban Outfitters
• Peach & Lily
• COSRX
• Alba Botanica
• Peace Out Skincare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.